FDA grants priority review to NDA for TAR-200 in BCG-unresponsive NMIBC
The new drug application for TAR-200 is supported by data from cohort 2 of the phase 2b SunRISe-1 trial.
The new drug application for TAR-200 is supported by data from cohort 2 of the phase 2b SunRISe-1 trial.
Purpose:Variability in the interpretation of videourodynamics studies limits reliable classification of kidney injury risk for patients with spina bifida. We developed machine learning models to…
In a panel meeting convened by the FDA, experts urged the agency to revise or remove the outdated boxed warning on hormone therapies for menopause.
The introduction of aspiration devices over the past few years has provided urologists a fascinating opportunity to render patients stone free in a revolutionizing way.…
Take a look back through some of the top stories from the first half of the year.
Howard B. Goldman, MD, who was the first to use the device in a clinical setting, shares his initial thoughts on the technology and its…
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Read our Cookies
Clinicians managing kidney transplant candidates with pulmonary hypertension need to be aware of possible excess risks.
The phase 2 Co-PSMA trial enrolled 50 patients with biochemical recurrence of prostate cancer.
Vikram M. Narayan, MD, discusses Emory’s recent shift to Apple products, aimed at reducing physician burnout and improving patient interactions.
Call for Core Video Abstracts 2025InstructionsThe American Urological Association is now accepting teaching video abstracts for inclusion in the AUA Core Curriculum. Teaching video abstracts…